Pal Singh-Kahlon

Pal Singh-Kahlon is the Director of Cytogenetics at Cancer Genetics. Pal has over forty years of experience in the field of cancer research. Pal began their career as a postdoctoral fellow at Universita Cattolica del Sacro Cuore in Rome, Italy. Pal then moved to the United States and joined Cancer Genetics Inc., where they worked for over thirty years. In their current position, they are responsible for the development and implementation of cytogenetic testing services for the diagnosis and prognosis of cancer patients.

Pal Singh-Kahlon has a Ph.D. from the University of Newcastle on Tyne, England.

Pal Singh-Kahlon reports to John A. Roberts, President & CEO. Pal Singh-Kahlon works with Ehab Elkhouly - Vice President of Clinical Affairs and Site Operations, Kamala K. Maddali - Vice President, Biopharma Collaborations & Companion Diagnostics, and Weiyi Chen - Director, Molecular Diagnostics.